Jan, 2016

U.S.A.
News / Corporate
Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and CEO: Paul Wotton, "Ocata") today announced that...
Read More

Dec, 2015

U.S.A.
News / Corporate
Astellas to Present at J.P. Morgan Healthcare Conference
Astellas Pharma today announced that the company's President and CEO Yoshihiko Hatanaka will present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 12, 2016 in San...
Read More

Nov, 2015

U.S.A.
News / Corporate
New Survey Examines How and to What Extent Americans Talk About Going to the Bathroom
Baltimore, MD, November 23, 2015—During Bladder Health Month, The American Urological Association (AUA) and Urology Care Foundation, in collaboration with Astellas, unveiled results from a...
Read More
U.S.A.
News / Corporate
Astellas to Acquire Ocata Therapeutics
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, "Astellas") and Ocata Therapeutics, Inc. (NASDAQ: OCAT, President and CEO: Paul Wotton, "Ocata"), a biotechnology company...
Read More

Feb, 2015

U.S.A.
News / Corporate
Astellas Pharma Launches the Newest Element in its Global Corporate Brand Campaign On CNN's Global Broadcast Network
Astellas Pharma Inc. (hereafter called Astellas or "the Company") President and CEO, Yoshihiko Hatanaka, announces the newest element of its on-going rollout of the Company's global corporate...
Read More